Table 1.
Baseline characteristics of entire participants
| Non-NAFLD cohort (n=494,852) | NAFLD cohort (n=77,020) | SMD | P-value | |
|---|---|---|---|---|
| Sex, male/female | 494,852 (100.0)/0 (0.0) | 77,020 (100.0)/0 (0.0) | ||
| Age (years) | 20.9±1.3 | 21.0±1.4 | 0.120 | <0.001 |
| Height (cm) | 174.3±5.6 | 174.4±5.8 | 0.017 | <0.001 |
| Weight (kg) | 69.7±8.3 | 86.7±11.2 | 1.725 | <0.001 |
| BMI (kg/cm2) | 22.9±2.3 | 28.4±3.1 | 2.066 | <0.001 |
| SBP (mm/Hg) | 118.2±12.0 | 125.7±12.5 | 0.613 | <0.001 |
| DBP (mm/Hg) | 69.7±9.0 | 75.0±9.8 | 0.563 | <0.001 |
| Lipid profile | ||||
| Total cholesterol (mg/dL) | 168.9±28.0 | 184.8±33.0 | 0.520 | <0.001 |
| HDL-cholesterol (mg/dL) | 55.0±10.5 | 48.9±9.5 | 0.602 | <0.001 |
| LDL-cholesterol (mg/dL) | 101.5±24.0 | 117.9±28.0 | 0.629 | <0.001 |
| Triglyceride (mg/dL) | 79.1±45.7 | 125.9±84.9 | 0.687 | <0.001 |
| Fasting glucose (mg/dL) | 90.4±8.1 | 92.3±8.9 | 0.228 | <0.001 |
| WBC (1,000/μL) | 6.6±1.6 | 7.2±1.7 | 0.384 | <0.001 |
| Hemoglobin (g/dL) | 15.5±0.9 | 15.9±0.9 | 0.393 | <0.001 |
| Hematocrit (%) | 45.6±2.5 | 46.5±2.5 | 0.356 | <0.001 |
| Platelet (109/L) | 241.9±45.4 | 258.2±49.4 | 0.344 | <0.001 |
| Creatinine (mg/dL) | 0.96±0.13 | 0.94±0.13 | 0.142 | <0.001 |
| AST (IU/L) | 23.8±18.7 | 28.9±16.6 | 0.292 | <0.001 |
| ALT (IU/L) | 18.8±10.8 | 46.1±38.9 | 0.958 | <0.001 |
| γGTP (IU/L) | 17.9±8.2 | 33.4±23.4 | 0.885 | <0.001 |
Values are presented as mean±standard deviation or number (%).
NAFLD, non-alcoholic fatty liver disease; SMD, standardized mean difference; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γGTP, gamma-glutamyl transpeptidase.